Study of AC-201 in Patients With Type 2 Diabetes Mellitus

NCT01276106 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

259

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: AC-201, 25mg
DRUG: AC-201, 50mg
DRUG: AC-201, 75mg
DRUG: Placebo

Sponsor

TWi Biotechnology, Inc.